E.M. Gilbert

1.7k total citations
45 papers, 1.2k citations indexed

About

E.M. Gilbert is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Transplantation. According to data from OpenAlex, E.M. Gilbert has authored 45 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Surgery, 20 papers in Cardiology and Cardiovascular Medicine and 16 papers in Transplantation. Recurrent topics in E.M. Gilbert's work include Transplantation: Methods and Outcomes (23 papers), Renal Transplantation Outcomes and Treatments (14 papers) and Mechanical Circulatory Support Devices (13 papers). E.M. Gilbert is often cited by papers focused on Transplantation: Methods and Outcomes (23 papers), Renal Transplantation Outcomes and Treatments (14 papers) and Mechanical Circulatory Support Devices (13 papers). E.M. Gilbert collaborates with scholars based in United States, Greece and Sweden. E.M. Gilbert's co-authors include Dale G. Renlund, Armando Huaringa, Richard W. Carlson, Marilyn T. Haupt, Michael R. Bristow, Michael R. Bristow, Ronald L. Menlove, John B. OʼConnell, J. G. Anderson and Frank G. Yanowitz and has published in prestigious journals such as Circulation, The Journal of Immunology and Journal of the American College of Cardiology.

In The Last Decade

E.M. Gilbert

40 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E.M. Gilbert United States 19 647 521 213 201 171 45 1.2k
Paolo Ferrazzi Italy 22 1.0k 1.6× 614 1.2× 511 2.4× 170 0.8× 112 0.7× 57 1.7k
Arnaud Ancion Belgium 14 413 0.6× 237 0.5× 113 0.5× 86 0.4× 26 0.2× 45 802
Tuba Khawaja United States 10 339 0.5× 306 0.6× 94 0.4× 201 1.0× 15 0.1× 13 702
D. Baron Australia 12 578 0.9× 390 0.7× 113 0.5× 93 0.5× 38 0.2× 35 942
Anna Clementi Italy 21 288 0.4× 134 0.3× 167 0.8× 79 0.4× 19 0.1× 53 938
Sven Laudi Germany 17 91 0.1× 177 0.3× 182 0.9× 97 0.5× 67 0.4× 55 843
Laurie G. Futterman United States 10 510 0.8× 287 0.6× 85 0.4× 69 0.3× 8 0.0× 44 765
J H Duff Canada 16 138 0.2× 540 1.0× 275 1.3× 51 0.3× 29 0.2× 42 1.1k
Takahiro Ohara Japan 18 622 1.0× 196 0.4× 214 1.0× 18 0.1× 110 0.6× 94 1.1k
Steven R. Rettke United States 19 283 0.4× 813 1.6× 305 1.4× 20 0.1× 92 0.5× 39 1.3k

Countries citing papers authored by E.M. Gilbert

Since Specialization
Citations

This map shows the geographic impact of E.M. Gilbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.M. Gilbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.M. Gilbert more than expected).

Fields of papers citing papers by E.M. Gilbert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.M. Gilbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.M. Gilbert. The network helps show where E.M. Gilbert may publish in the future.

Co-authorship network of co-authors of E.M. Gilbert

This figure shows the co-authorship network connecting the top 25 collaborators of E.M. Gilbert. A scholar is included among the top collaborators of E.M. Gilbert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.M. Gilbert. E.M. Gilbert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kapelios, Chris J., Lars H. Lund, Omar Wever‐Pinzon, et al.. (2022). Right Heart Failure Following Left Ventricular Device Implantation: Natural History, Risk Factors, and Outcomes: An Analysis of the STS INTERMACS Database. Circulation Heart Failure. 15(6). e008706–e008706. 49 indexed citations
2.
Kfoury, Abdallah G., Dylan V. Miller, Gregory L. Snow, et al.. (2015). Mixed cellular and antibody-mediated rejection in heart transplantation: In-depth pathologic and clinical observations. The Journal of Heart and Lung Transplantation. 35(3). 335–341. 20 indexed citations
3.
Miller, Dylan V., Charles German, Mónica P. Revelo, et al.. (2013). Outward Remodeling of Coronary Arteries in Cardiac Allograft Vasculopathy Is Reduced Compared to Native Atherosclerosis. The Journal of Heart and Lung Transplantation. 32(4). S244–S245. 1 indexed citations
4.
Wever‐Pinzon, Omar, Josef Stehlik, Abdallah G. Kfoury, et al.. (2012). Abstract 19188: Effects of Continuous-Flow Left Ventricular Assist Device Unloading on the Diastolic Function of the Failing Human Heart. Circulation. 126(suppl_21). 1 indexed citations
5.
Drakos, Stavros G., Abdallah G. Kfoury, James W. Long, et al.. (2006). Low-Dose Prophylactic Intravenous Immunoglobulin Does Not Prevent HLA Sensitization in Left Ventricular Assist Device Recipients. The Annals of Thoracic Surgery. 82(3). 889–893. 15 indexed citations
6.
Massie, Barry M., Jeanenne J. Nelson, Mary Ann Lukas, et al.. (2004). 821-2 Characteristics of heart failure patients in clinical practice: How do they relate to ejection fraction?. Journal of the American College of Cardiology. 43(5). A195–A195. 1 indexed citations
7.
Fowler, Michael B., Jeanenne J. Nelson, Mary Ann Lukas, et al.. (2004). 821-3 Evaluation of beta-blocker does in community-based treatment of heart failure. Journal of the American College of Cardiology. 43(5). A196–A196. 1 indexed citations
8.
Greenberg, Barry, Jeanenne J. Nelson, Mary Ann Lukas, et al.. (2004). 1172-71 Practical predictors of clinical outcomes in patients initiating beta-blockers for heart failure: Findings of a community-based registry. Journal of the American College of Cardiology. 43(5). A421–A421. 1 indexed citations
9.
Fowler, Michael B., Montserrat Vera‐Llonch, Gerry Oster, et al.. (2001). Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. Journal of the American College of Cardiology. 37(6). 1692–1699. 53 indexed citations
10.
Bristow, Michael R., et al.. (1998). The role of third-generation beta-blocking agents in chronic heart failure. Clinical Cardiology. 21(S1). I3–I13. 60 indexed citations
11.
Taylor, Ronald P., William Sutherland, Edward N. Martin, et al.. (1997). Bispecific monoclonal antibody complexes bound to primate erythrocyte complement receptor 1 facilitate virus clearance in a monkey model. The Journal of Immunology. 158(2). 842–850. 37 indexed citations
12.
Bristow, Michael R., William T. Abraham, Tsutomu Yoshikawa, et al.. (1997). Second- and Third-Generation Beta-Blocking Drugs in Chronic Heart Failure. Cardiovascular Drugs and Therapy. 11(S1). 291–296. 27 indexed citations
13.
Gill, Edward A., et al.. (1995). Left ventricular mass increases during cardiac allograft vascular rejection. Journal of the American College of Cardiology. 25(4). 922–926. 21 indexed citations
14.
Gilbert, E.M.. (1991). Double-blind, placebo-controlled (P), comparison of enoximone (E) and dobutamine (D) infusions in moderate to severe congestive heart failure patients (NYHA III–IV). Journal of the American College of Cardiology. 17(2). A274–A274. 1 indexed citations
15.
Crandall, Brian G., E.M. Gilbert, Dale G. Renlund, et al.. (1990). A RANDOMIZED TRIAL OF THE IMMUNOSUPPRESSIVE EFFICACY OF VINCRISTINE IN CARDIAC TRANSPLANTATION. Transplantation. 50(1). 34–37. 4 indexed citations
16.
Gilbert, E.M., J. G. Anderson, David Deitchman, et al.. (1990). Long-term β-Blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: A double-blind, randomized study of bucindolol versus placebo. The American Journal of Medicine. 88(3). 223–229. 197 indexed citations
17.
Bristow, Michael R., et al.. (1988). Myocardial  - and  -adrenergic receptors in heart failure: is cardiac-derived norepinephrine the regulatory signal?. European Heart Journal. 9(suppl H). 35–40. 50 indexed citations
18.
Bristow, Michael R., E.M. Gilbert, John B. OʼConnell, et al.. (1988). OKT3 Monoclonal Antibody in Heart Transplantation. American Journal of Kidney Diseases. 11(2). 135–140. 19 indexed citations
19.
Renlund, Dale G., E.M. Gilbert, John B. OʼConnell, et al.. (1987). Age-associated decline in cardiac allograft rejection. The American Journal of Medicine. 83(3). 391–398. 50 indexed citations
20.
Gilbert, E.M., et al.. (1986). The Effect of Fluid Loading, Blood Transfusion, and Catecholamine Infusion on Oxygen Delivery and Consumption in Patients with Sepsis 1, 2. American Review of Respiratory Disease. 134(5). 873–878. 233 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paolo Ferrazzi Breakdown of academic impact, for papers by Arnaud Ancion Breakdown of academic impact, for papers by Tuba Khawaja Breakdown of academic impact, for papers by D. Baron Breakdown of academic impact, for papers by Anna Clementi Breakdown of academic impact, for papers by Sven Laudi Breakdown of academic impact, for papers by Laurie G. Futterman Breakdown of academic impact, for papers by J H Duff Breakdown of academic impact, for papers by Takahiro Ohara Breakdown of academic impact, for papers by Steven R. Rettke
Rankless by CCL
2026